CGN — Cognetivity Neurosciences Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Cognetivity Neurosciences, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.379 | 0.578 | 1.36 | 1.38 | 2.24 |
Net Total Receivables | 0.057 | 0.047 | 0.082 | 0.432 | 0.371 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.69 | 0.711 | 1.75 | 1.86 | 2.66 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.026 | 0.037 | 0.044 | 0.063 | 0.062 |
Net Intangible Assets | |||||
Total Assets | 0.716 | 0.748 | 1.83 | 2 | 2.83 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.237 | 1.01 | 0.965 | 5.56 | 10.6 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.237 | 1.01 | 0.965 | 7.68 | 12.7 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.479 | -0.263 | 0.863 | -5.68 | -9.89 |
Total Liabilities & Shareholders' Equity | 0.716 | 0.748 | 1.83 | 2 | 2.83 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |